SALT LAKE CITY, Nov. 11 /PRNewswire/ -- Great Basin Scientific, Inc., has named Laurence Rea vice president of operations, according to Ryan Ashton, president and CEO of Great Basin Scientific, a privately held life sciences company developing novel, point-of-care molecular diagnostic solutions. Rea will be responsible for creating the regulatory, manufacturing and quality control systems and staffing needed to take the company's molecular diagnostic products through clinical trials and to market. Rea also will oversee the set up of the company's manufacturing facilities in Longmont, Colo.
"We're very excited to bring someone of Larry's caliber on board with us at a time when his proven management skills will be highly valuable to our product development and eventual product launches," said Ashton. "He is a veteran of the industry who has seen many products successfully through the manufacturing and regulatory process and his recent past experience at BioStar, manufacturing a chip-based rapid test, is similar to Great Basin's chip-based molecular diagnostic system."
Rea brings to Great Basin Scientific more than 20 years of engineering and manufacturing experience, of which eight years were spent managing a Good Manufacturing Practice (GMP) facility for BioStar, Inc., a subunit of Inverness Medical Innovations, Inc., with revenues that exceeded $30 million during Rea's tenure. As general manager at BioStar, Rea was responsible for FDA regulatory requirements and the overall performance of the business unit.
Rea has particular expertise in seeing products through the regulatory process. During his past eight years at BioStar, Rea and his staff were responsible for seeing multiple diagnostic products through the 510K approval process. He also oversaw the pre-clinical and clinical trials at hospitals and clinics, including institutional review board (IRB) approvals from multiple organizations.
Rea holds a Bachelor of Science degree in Physics from University of Colorado, Boulder, Colo.
"I am very excited to be working with Great Basin Scientific to help bring this much needed technology to the healthcare industry, and ultimately, develop a new standard of care for physicians and their patients," said Rea.
About Great Basin Scientific
Great Basin Scientific, Inc. is a privately held life sciences company that commercializes breakthrough technologies for the molecular, rapid diagnostic testing market. The company is dedicated to development of simple yet powerful point-of-care technology and products that improve automation, throughput, scalability, reliability and ease of use of rapid diagnostic testing for point-of-care settings such as physician's office labs, small-medium hospital labs and other moderately complex laboratory facilities. The company's laboratory and manufacturing facilities are located in Longmont, Colo.
Great Basin Scientific was founded in 2003 by David Ward, Ph.D., deputy director of the Nevada Cancer Institute, formerly of Yale University of Medicine, and Anthony R. Torres, M.D., senior scientist and director of the Immunogenetics Laboratory, Utah State University. More information can be found on the company's Web site at http://www.gbscience.com.
CONTACT: Mary-Katharine Juric of Edelman, +1-415-486-3269,
email@example.com, for Great Basin Scientific, Inc.
Web site: http://www.gbscience.com/